Effects of the Novel Inhaled Phosphodiesterase-4 (PDE4) Inhibitor CHF6001 in Targeting Markers of Inflammation in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Autor:	Aida Emirova, Dave Singh, Marie Anna Nandeuil, Brendan Colgan, Germano Lucci, Oliver Kornmann, Brianr R. Leaker, Mirco Govoni, Silvia Geraci, Kai Michael Beeh, E. Calabro Rocco, Henrik Watz
Rok vydání:	2019
Předmět:	Moderate to severe medicine.medical_specialty Chronic bronchitis COPD business.industry Pulmonary disease Inflammation medicine.disease Gastroenterology Phosphodiesterase-4 Internal medicine medicine In patient medicine.symptom business
Zdroj:	D101. CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bcab39aa6ff2a02ce9b47eca747abcb4 https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7095 Zobrazit plný text záznamu